An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Some professionals said the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking fines, prosecution or prison.
Platform Reaction and Material Elimination
Based on the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Research also found communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for preparing or administering at home.
After moments of entering one community, a vendor shared contact information, where the majority of purchases occur. The seller provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.
Item Details and Pricing
Inside these communities, posts display dark colored packages with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A representative for Telegram stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to potentially serious medical dangers”.
